LRTIs (3) Flashcards
list the LRTIs we are expected to know
- influenza
- acute bronchitis
- acute exacerbation of chronic bronchitis (AECB)
- community acquired pneumonia (CAP)
- nosocomial pneumonia
- empyema/lung abcess
- TB
epidemiology of influenza
distinct outbreaks every year–>typically in winter months
begin abruptly and attack about 10-20% of the population
transmission depends on the virus and the susceptibility of the population
death rates are disproportionately high in elderly and infants
what causes vaccine mismatches with influenza
antigenic drift
what causes influenza
influenza A virus
3 major subtypes of HEMAGLUTININ (H1, H2, H3)
2 subtypes of NEURAMINIDASE (N1, N2)
have ability to undergo changes in antigenic characteristics of envelope glycoproteins
how does the influenza A virus cause infection and spread
HEMAGLUTININ binds to SIALIC ACID on epithelial cell surface to initiate infection
NEURAMINIDASE cleaves the link between progeny and host cell, allowing new virions to escape
when does viral shedding of influenza A begin
24-48 hours before symptom onset
clinical presentation of influenza
ABRUPT onset
fever, cough, headache, myalgias, malaise, sore throat, rhinorrhea
exam usually unremarkable–> flushing and mild cervical lymphadenopathy in some patients
uncomplicated patients improve in 3-5 days
viral shedding stops after 6-7 days
what is the most common complication of influenza
pneumonia
Tx for influenza
most cases are self limited and dont require treatment
antivirals are indicated for the severely ill or those at risk of complications
Ab Tx of secondary infection when needed
in a patient with influenza in which antivirals are indicated, what is the medication used
oseltamivir (Tamiflu)
needs to be given early to see benefit
bacterial causes of acute bronchitis
mycoplasma pneumoniae
chlamydophila pneumoniae
Bordatella pertussis (if cough >3 weeks suspect this)
viral causes of acute bronchitis
respiratory viruses :
influenza coronaviruses adenovirus entero/rhinoviruses RSV measles
is acute bronchitis most often viral or bacterial
viral
clinical presentation of acute bronchitis
cough
what is one way to distinguish between viral and bacterial causes
procalcitonin levels (>0.25 mcg/L suggest bacterial)
what causes AECB
about 50% viral cause
how is AECB diagnosed (criteria)
PRODUCTIVE cough for at least 3 months/year for the last 2 consecutive years=chronic bronchitis
criteria for AECB (need at least 2 to diagnose):
- increased sputum volume
- increased sputum purulence
- increased dyspnea
how is AECB prevented
COPD patients should receive flu vaccine yearly and pneumococcal vaccine every 6 years
what is CAP
pneumonia in a person who is not has not recently been hospitalized
top disease in children worldwide, and among adults in the US
how do pathogens reach the lungs to cause infection in CAP
via inhalation, aspiration or by blood
blood = less common
what are some conditions that may raise your risk for CAP
alcoholism diabetes CHF COPD smoking aspiration prone post-influenza cystic fibrosis
causative agents of CAP in neonates
- GBS
- E. Coli
- S. aureus
- Pseudomonas
- C. trachomatis
causative agents of CAP in infants
- RSV
- influenza
- S. pneumoniae
- H. influenzae
- S. aureus
causative agents of CAP in adults
more often bacterial than viral
STREP PNEUMONIAE = most common cause
how do you diagnose CAP
Hx, physical exam
**CREPITATIONS/RALES (crackles)
Diagnostic testing–> sputum (gram stain), bronchoscopy/lung biopsy/thoracentesis, CBC/procalcitonin/blood cultures/serology/urine antigen, diagnostic imaging
CXR–> location and nature of infiltrates, cavitation, volume loss, pleural fluid, mediastinal adenopathy
Tx for S. pneumoniae (in CAP)
empiric = AMOXICILLIN in high dose
note that a significant number of isolates are resistant to macrolides and doxycyline
what agents cause hospital acquired pneumonia
Enterobacteriaceae–> E. coli, Klebsiella, Serratia
S. aureus
what agents cause ventilator acquired pneumonia
Pseudomonas aeruginosa
+E. coli, Klebsiella, Serratia and S. aureus
empiric Tx for HAP
ceftriaxone
empiric Tx for VAP
pipercillin/tazobactam
what is a lung abcess
microbiological infection causing necrosis of lung parenchyma
producing 1 or more cavities
what agents tend to cause lung abcesses
mouth flora/oral anaerobes
Eikenella corrodens
Strep spp
Tx for lung abcess
clindamycin
or penicillin with metronidazole
consider TB/fungal/malignancy if cavitiations without air fluid level
what is pleural effusion
fluid in the pleural space
what is empyema
infection of fluid in the pleural space
risk factors for pleural effusion/empyema
HIV
neoplasm
pulmonary disease
alcoholism
what agents cause empyema most commonly
- if pre-antibiotic:
S. PNEUMONIAE (60-70%)
S. pyogenes
S. aureus - if post-antibiotic:
anaerobes (bacteroides, fusobacterium, peptostreptococcus)
Strep. anginosus
enterobacteriaeceae
how is empyema diagnosed
drain pleural space and obtain sample to gram stain and determine C & S to guide therapy
ultrasound
xray
clinical presentation of empyema
cough
chest pain
SOB
fever
Tx of empyema
empiric = CEFTRIAXONE
add metronidazole if chronic
what is the global prevalence of TB
30%
how is TB passed
it is carried in AIRBORNE particles and then inhaled
inhalation can result in 3 outcomes
- immediate clearance
- primary active disease
- latent infection with possibility of active disease later in life
where in Canada is TB prevalence higher
- in medically underserved communities
- urban poor, homeless
- prison inmates
- alcoholics and IV drug users
- elderly
- foreign-born
- contacts of active cases
what causes TB
mycobacterium
acid fast bacilli
strictly aerobic
slow growing (2-6 weeks)
pathogenic: M. tuberculosis, M. bovis, M. ulcerans
potentially pathogenic: M. kansasii, M. avium compex
TB pathophysiology
M. tuberculosis organisms are inhaled and then engulfed by macrophages, which forms a cavitation
host immune response typically limits spread but bacilli can remain dormant for years
clinical presentation of TB
PULM INFECTION with COUGH, hemoptysis, dyspnea weight loss NIGHT SWEATS low grade fever chest pain
how do you diagnose TB
most commonly through MICROSCOPY–ZIEHL-NEELSON stain for acid fast bacilli
culture or molecular probe is necessary to distinguish from nontuberculous mycobacteria (NTM)
culture necessary to test drug susceptibility
TB skin test–MANTOUX
does a - TB skin test rule out active infection
no
how does the TB skin test work
interferon gamma release assays (IGRA)
measures cell mediated immune response
T cells in patients blood bind to TB antigen and release IFN-gamma
increased IFN-gamma expected in those who have been exposed
Tx for TB
isoniazid rifampin ethambutol streptomycin pyrazinamide
duration of 6 months to two years